To test this hypothesis, we measured the steady state protein levels of ARRDC3 in 12 breast cancer cell lines with different subtypes (4 luminal and 8 TNBC subtypes) (Figure 3A). This evidence concerns the gene ARRDC3 and breast carcinoma.